Cancer And Premature Mortality In Ireland: An Employer's Perspective Following The Friction Cost Approach. by Hanly, P et al.
CANCER AND PREMATURE MORTALITY IN IRELAND: AN EMPLOYER’S 
PERSPECTIVE FOLLOWING THE FRICTION COST APPROACH 
Paul Hanly1, Alison Pearce2, Linda Sharp3 
 
1National College of Ireland, Mayor Street, Dublin 1, Ireland 
2National Cancer Registry Ireland, Cork Airport Business Park, Kinsale Road, Cork, Ireland 





Cancer is the second leading cause of death in Ireland accounting for approximately 30% of 
all deaths. Of these, almost a third arise in those of working age. As well as the public health 
burden, cancer also imposes economic costs on society in general and employers in 
particular. This study measured the productivity costs associated with cancer-related 
premature mortality from an employer’s perspective in Ireland.  
METHODS 
Data was abstracted on the average annual number of cancer deaths between the ages of 15 
and 64 in Ireland during 2005-2009 by 5-year age group and sex from the World Health 
Organization Cancer Mortality Database. The friction cost approach was used to value all 
premature cancer deaths (and those for the ten most common cancer sites in males and 
females), over a defined friction period (base-case = 79 days), by gross gender- and age-
specific wages, adjusted for labour market characteristics. In sensitivity analyses estimates 
were adjusted for ‘multiplier effects’ associated with modern work practices and for changing 
labour market conditions.  
RESULTS 
The all-cancer premature mortality cost was €14.3 million in 2009. Costs were more than 
two-fold higher for males than females. Base-case estimates were sensitive to changes in 
labour markets conditions and decreased by 42% following adjustment for increased 
unemployment levels (from 4.6% to 12.7%). Productivity costs were higher in settings with 
modern team-based working practices rising by almost 30% in the case of females (17% for 
males). 
CONCLUSIONS 
Employers are becoming increasingly aware of the adverse economic effects of illness. Our 
results reveal the magnitude of productivity costs associated with cancer-related premature 
mortality from an employer’s perspective in Ireland. These results provide a sense of the 
types and magnitude of costs that are explicitly excluded from economic evaluations that fail 
to encompass a broader social perspective. 
